Symposium 2012 Video

John Marshall, MD, Director, Ruesch Center for the Cure of GI Cancers
Fighting a Smarter War Against Cancer: Empowering Patients Through Clinical Trials

Since 2009, the Ruesch Center has hosted a series of multidisciplinary symposia to engage the public in a discussion of the future of cancer research and the use of personalized medicine as the key to a cure. While the earlier events focused mainly on the science behind personalized medicine, the 2012 symposium, Fighting a Smarter War Against Cancer: Empowering Patients Through Clinical Trials, seeks to drive the conversation around the impact of health care reform and the concept of value in medicine.

Videos by subject and speaker are available online.


Day 1: Accelerating the Cure through Clinical Research

Welcome
John Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center

The State of Cancer Clinical Research in the US and the World: Progress at the 3% Accrual Rate
Moderator: Margo Michaels
Executive Director and President, Education Network to Advance Cancer Clinical Trials

The Role of Government in Clinical Research: Restructuring the NCI's Clinical Trials Program
James Zwiebel, MD
Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute

The Projected Impact of a 20% Accrual Rate on the Cost of Drug Development
Todd Shuster, MD
Senior Director, Clinical Development, and Oncology Therapeutic Area Co-Leader, PAREXEL International

Accrual in the Community, and the Impact of Sudden Success
Lori Minasian, MD, FACP
Deputy Director, Division of Cancer Prevention, National Cancer Institute

Question and Answer Session

Going from 3% to 20%+: The Potential Impact on the Race
Introduction: John L. Marshall, MD

Schafer Memorial Lecture
Deborah Schrag, MD, MPH
Associate Professor, Department of Medicine, Harvard Medical School, Adult Oncology, Dana-Farber Cancer Institute

Panel Discussion
Moderator: Brian Rye
Health Care Financial Analyst for Bloomberg Government

Panelists:
Alan Wertheimer, PhD
Senior Research Scholar, Department of Bioethics, National Institutes of Health

Carol Palackdharry, MD, MS
Medical Director, ActiveHealth Management; Clinical Lead, Oncology Condition Analysis, Aetna

Louis Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services

Engaging the Other 97%: Why Aren't Cancer Patients Up in Arms?
Moderator: Amanda Bennett
Author, "The Cost of Hope: A Memoir"
Executive Editor, Bloomberg News

Featuring:

  • Ruesch Board Members
  • Patients and Family Members
  • David L. Evans, MD,
    Senior Vice President, Clinical Programs, ActiveHealth Management
  • Howard Fingert, MD, FACP
    Senior Medical Director, Millennium, the Takeda Oncology Company
  • Ruesch Center Faculty

 

Day 2: Demystifying Clinical Research for Patients

Understanding Clinical Trials, Research and Patient Partnering
John L. Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center

Clinical Trials 101
Jim Luecht
Lung Cancer & Brain Tumor Clinical Research Coordinator
Georgetown Lombardi Comprehensive Cancer Center

Genomics and Cancer Research
Subha Madhavan, PhD
Director of the Innovation Center for Biomedical Informatics,
Georgetown University Medical Center

The Cost of Hope
Amanda Bennett
Author, "The Cost of Hope: A Memoir"; Executive Editor, Bloomberg News

Barriers to Patient Accrual
Lucile L. Adams-Campbell, PhD
Professor of Oncology and Associate Dean, Community Health & Health Disparities Research
Associate Director, Minority Health & Health Disparities Research
Georgetown Lombardi Comprehensive Cancer Center

Cost to Patients and Insurance Coverage
Julie Feurtado, RN, BSN
Clinical Nurse Coordinator
Georgetown Lombardi Comprehensive Cancer Center

Engaging Communities in Cancer Clinical Trials: How Community Ambassadors are Making a Difference
Margo Michaels
Executive Director and President of ENACCT

Roundtable Discussion (all speakers)
Moderator: John L. Marshall, MD